FI955429A0 - 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi - Google Patents

1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi

Info

Publication number
FI955429A0
FI955429A0 FI955429A FI955429A FI955429A0 FI 955429 A0 FI955429 A0 FI 955429A0 FI 955429 A FI955429 A FI 955429A FI 955429 A FI955429 A FI 955429A FI 955429 A0 FI955429 A0 FI 955429A0
Authority
FI
Finland
Prior art keywords
pct
optionally substituted
anxiety
parkinson
depression
Prior art date
Application number
FI955429A
Other languages
English (en)
Swedish (sv)
Other versions
FI955429A (fi
Inventor
Paul John Harris
David John Heal
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of FI955429A0 publication Critical patent/FI955429A0/fi
Publication of FI955429A publication Critical patent/FI955429A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI955429A 1993-05-12 1995-11-10 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi FI955429A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309749A GB9309749D0 (en) 1993-05-12 1993-05-12 Therapeutic agents
PCT/EP1994/001494 WO1994026704A1 (en) 1993-05-12 1994-05-07 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease

Publications (2)

Publication Number Publication Date
FI955429A0 true FI955429A0 (fi) 1995-11-10
FI955429A FI955429A (fi) 1996-01-03

Family

ID=10735317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955429A FI955429A (fi) 1993-05-12 1995-11-10 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi

Country Status (29)

Country Link
US (1) US5652271A (fi)
EP (1) EP0715620B1 (fi)
JP (2) JP3606326B2 (fi)
KR (1) KR100295264B1 (fi)
AT (1) ATE172719T1 (fi)
AU (1) AU681669B2 (fi)
BG (1) BG61913B1 (fi)
BR (2) BR9406577A (fi)
CZ (1) CZ290711B6 (fi)
DE (1) DE69414264T2 (fi)
DK (1) DK0715620T3 (fi)
ES (1) ES2124411T3 (fi)
FI (1) FI955429A (fi)
GB (1) GB9309749D0 (fi)
HU (1) HU211124A9 (fi)
IL (1) IL109635A (fi)
LV (1) LV11320A (fi)
MY (1) MY110773A (fi)
NO (1) NO305165B1 (fi)
NZ (1) NZ266776A (fi)
PH (1) PH30418A (fi)
PL (1) PL176400B1 (fi)
RO (1) RO115519B1 (fi)
RU (1) RU2135467C1 (fi)
SK (1) SK281257B6 (fi)
TW (1) TW318833B (fi)
UA (1) UA42722C2 (fi)
WO (1) WO1994026704A1 (fi)
ZA (1) ZA943241B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518988A1 (de) * 1995-05-29 1996-12-05 Basf Ag Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
GB9915617D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
PL2011796T3 (pl) * 2006-04-26 2015-03-31 Toyama Chemical Co Ltd Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10098845B2 (en) 2013-10-07 2018-10-16 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
AU6843394A (en) 1994-12-12
DE69414264T2 (de) 1999-03-25
WO1994026704A1 (en) 1994-11-24
NO305165B1 (no) 1999-04-12
LV11320A (lv) 1996-06-20
FI955429A (fi) 1996-01-03
CZ293695A3 (en) 1996-06-12
BG100127A (bg) 1996-07-31
ATE172719T1 (de) 1998-11-15
IL109635A0 (en) 1994-11-11
SK281257B6 (sk) 2001-01-18
BR1100306A (pt) 2002-04-02
NZ266776A (en) 1998-02-26
IL109635A (en) 1998-03-10
PH30418A (en) 1997-05-09
GB9309749D0 (en) 1993-06-23
AU681669B2 (en) 1997-09-04
US5652271A (en) 1997-07-29
BG61913B1 (bg) 1998-09-30
ZA943241B (en) 1994-11-14
MY110773A (en) 1999-03-31
CZ290711B6 (cs) 2002-09-11
DE69414264D1 (de) 1998-12-03
RU2135467C1 (ru) 1999-08-27
KR100295264B1 (ko) 2001-09-17
JPH08510222A (ja) 1996-10-29
BR9406577A (pt) 1996-01-30
EP0715620B1 (en) 1998-10-28
TW318833B (fi) 1997-11-01
ES2124411T3 (es) 1999-02-01
HU211124A9 (en) 1995-10-30
JP2004331669A (ja) 2004-11-25
PL176400B1 (pl) 1999-05-31
EP0715620A1 (en) 1996-06-12
NO954542D0 (no) 1995-11-10
JP3606326B2 (ja) 2005-01-05
NO954542L (no) 1996-01-10
DK0715620T3 (da) 1999-07-05
UA42722C2 (uk) 2001-11-15
RO115519B1 (ro) 2000-03-30
PL311628A1 (en) 1996-03-04
SK140795A3 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
FR2734816B1 (fr) Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK0667866T3 (da) 1,4-benzothiazepiner anvendelige som neurologiske midler
PL335696A1 (en) Substituted 4-arylmethylene-2-imino-2,3-dihydrothiasoles and their derivatives as well as their pharmaceutical application
FI955429A0 (fi) 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi
GR3033786T3 (en) Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
KR940005534A (ko) 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
CA2162706A1 (en) 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
JO1809B1 (en) Therapeutic agents
ES2116880A1 (es) Farmacos y composiciones farmaceuticas para su uso en el tratamiento de enfermedades.
ES2149216T3 (es) Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos.